Strategies for Selective Pathogenic B Cell Depletion in Inflammatory Diseases
- Identifying disease-specific B cell populations driving autoimmune diseases
- Benefit and challenges of targeting pathogenic B cells; identification of disease relevant animal models
- Prioritising targets by balancing specificity, patient coverage, and safety to enable precision depletion while minimising off-target immune suppression